Extractables and Leachables USA sponsors and exhibitors are leaders in the field who present innovative products and services to an audience of industry professionals and decision makers. Thank you to our sponsors for making this event possible!
PPD, part of Thermo Fisher Scientific, is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help clients and partners bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health.
The dedicated and highly specialized extractables and leachables (E&L) team in the PPD® Laboratories GMP lab has more than 15 years of experience providing full-program support for all aspects of E&L studies, including overall study design/consulting, container/closure selection as well as manufacturing process qualification and validation. Our E&L team and toxicology experts work with clients to make informed decisions on which extractable compounds will be monitored as leachables in long-term stability studies, development of extractable and leachable methods, leachable stability testing, batch extractables testing and USP compendia testing support.
Twitter: @PPDCRO
We are recognized as the global benchmark for quality and integrity. Our 96,000 employees operate a network of 2,700 offices and laboratories, working together to enable a better, safer and more interconnected world.
Wherever you are, whatever your industry, our experts worldwide provide specialized solutions to make your business faster, simpler and more efficient.
“VR Analytical is a leading provider of extractables and leachables (E&L) testing services. We offer customized test packages that bio-pharmaceutical end users and suppliers need to mitigate the potential risk of E&L substances reaching patients. Using a science-based, partnership-driven approach, and supported by one of the industry’s largest extractables databases, we help our customers find the most efficient paths to regulatory approval. Our knowledge of the E&L regulatory landscape is based on years of direct contribution to the industry, through participation in standards setting organizations, and presentation of novel research conducted in our lab.
Interested in sponsoring this year or beyond? Reach out to Kelli Lewis, klewis@smithers.com.